CARE AND TRIAL SITE REGISTRY FOR NEUROMUSCULAR AND NEURODEGENERATIVE DISEASES (CTSR)
The aim of the Care and Trial Site Registry (CTSR) is to help the pharmaceutical industry and clinical investigators select trial sites as well as to help to identify potential partners for upcoming research projects. The CTSR provides information relevant to clinical studies (such as personnel, facilities and patient population) and to the assessment as centres of expertise according to the EUCERD criteria. CTSR is an IRDiRC recognized resource.
The toolbox has been developed through funding from the EJP RD project.
The European Joint Programme on Rare Diseases is an initiative that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement N°825575